CoraLite® Plus 647 Anti-Human DPP4/CD26 (BA5b) Mouse IgG2a Recombinant Antibody

DPP4/CD26 Uni-rAbTM Recombinant Antibody for FC (Intra)
Cat No. CL647-65574

产品说明书

CloneNo. BA5b

宿主/亚型

Mouse / IgG2a

种属反应性

human

应用

FC (Intra)

CD26, ADABP, ADCP 2, ADCP2, ADCP-2

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  {{ptg:cur_Conjugation}}
规格: 

-/ -


经过测试的应用

Positive FC (Intra) detected inhuman PBMCs

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

CL647-65574 targets DPP4/CD26 in FC (Intra) applications and shows reactivity with human samples.

经测试应用 FC (Intra) Application Description
经测试反应性 human
免疫原 A human T cell clone 种属同源性预测
宿主/亚型 Mouse / IgG2a
抗体类别 Recombinant
产品类型 Antibody
全称 dipeptidyl-peptidase 4
别名 CD26, ADABP, ADCP 2, ADCP2, ADCP-2
计算分子量 88 kDa
GenBank蛋白编号BC013329
基因名称 DPP4
Gene ID (NCBI) 1803
RRIDAB_3673626
偶联类型 CoraLite® Plus 647 Fluorescent Dye
最大激发/发射波长654 nm / 674 nm
形式 Liquid
纯化方式Protein A purification
储存缓冲液 PBS with 0.09% sodium azide and 0.5% BSA.
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

CD26, also known as DPP4 (dipeptidyl peptidase-4), is a 110 kDa type II cell-surface glycoprotein widely expressed on T cells, activated B cells, activated NK cells and myeloid cells as well as on epithelial cells, fibroblasts, mesothelium, and endothelial cells of a variety of tissues (PMID:33777580; 26919392). It has ecto-enzyme activity in its extracellular domain and cleaves amino-terminal dipeptides with either L-proline or L-alanine at the penultimate position (PMID: 9553764). CD26 plays roles in diverse biological processes such as immunoregulation, glucose homeostasis, and tumorigenesis (PMID: 33777580).

实验方案

Product Specific Protocols
FC protocol for CL Plus 647 DPP4/CD26 antibody CL647-65574Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...